159 related articles for article (PubMed ID: 11399815)
61. Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study.
Kaufman RM; Marks DC; Flamand Y; Acker JP; Brown BL; Olafson C; Marschner S; Pandey S; Papari M; Petraszko T; Serrano K; Ward D; Bazin R;
Transfusion; 2023 Nov; 63(11):2072-2082. PubMed ID: 37818894
[TBL] [Abstract][Full Text] [Related]
62. Genetic variations of CD36 and low platelet CD36 expression - a risk factor for lipemic plasma donation in Taiwanese apheresis donors.
Lo SC; Lin KH; Hsieh HH; Lin DT; Hu CY
Vox Sang; 2016 Apr; 110(3):236-43. PubMed ID: 26528880
[TBL] [Abstract][Full Text] [Related]
63. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
Fontana S; Rados L; Schmid P; Leibundgut EO; Taleghani BM
Transfusion; 2011 Sep; 51(9):2034-43. PubMed ID: 21438883
[TBL] [Abstract][Full Text] [Related]
64. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
Lokhande T; Thomas S; Kumar G; Bajpai M
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
[TBL] [Abstract][Full Text] [Related]
65. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
Schrezenmeier H; Seifried E
Vox Sang; 2010 Jul; 99(1):1-15. PubMed ID: 20059760
[TBL] [Abstract][Full Text] [Related]
66. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
Thiele T; Alt-Mayer T; Greinacher A; Bux J
Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
[TBL] [Abstract][Full Text] [Related]
67. Apheresis affects bone and mineral metabolism.
Amrein K; Katschnig C; Sipurzynski S; Stojakovic T; Lanzer G; Stach E; Pieber TR; Dobnig H
Bone; 2010 Mar; 46(3):789-95. PubMed ID: 19922822
[TBL] [Abstract][Full Text] [Related]
68. Discussion on the recruitment strategy for apheresis platelet donors in Chongqing during a public health emergency
Cheng Y; Xie C; Tian Y; Wang F; Liu X; Cheng D
Front Public Health; 2024; 12():1365433. PubMed ID: 38651129
[TBL] [Abstract][Full Text] [Related]
69. Comparative Analysis of Various Aspects of Plateletpheresis on the Fenwal Amicus and Fresenius COM.TEC Cell Separator Instruments.
Philip J; Biswas AK; Chatterjee T; Mallhi RS
Lab Med; 2014; 45(4):315-23. PubMed ID: 25316663
[TBL] [Abstract][Full Text] [Related]
70. Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency.
Li H; Condon F; Kessler D; Nandi V; Rebosa M; Westerman M; Shaz BH; Ginzburg Y
J Clin Apher; 2016 Dec; 31(6):551-558. PubMed ID: 26915437
[TBL] [Abstract][Full Text] [Related]
71. The effect of repeated stimulated granulocyte donations on hematopoietic indexes in donors: a 24-year donor center experience.
Szymanski J; Troendle J; Leitman S; Hong H; Yau YY; Cantilena C
Transfusion; 2019 Jan; 59(1):259-266. PubMed ID: 30444537
[TBL] [Abstract][Full Text] [Related]
72. [Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use?].
Lozano ML; Rivera J; Vicente V
Med Clin (Barc); 2012 May; 138(12):528-33. PubMed ID: 21807386
[TBL] [Abstract][Full Text] [Related]
73. [Demography and donation frequencies of blood and plasma donor populations in Germany. Update 2010 and 5-year comparison].
Ritter S; Hamouda O; Offergeld R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):914-22. PubMed ID: 22842884
[TBL] [Abstract][Full Text] [Related]
74. Demographics of apheresis platelet donors in five blood centers in China.
Guo N; Wang J; Ness P; Yao F; Dong X; Bi X; Mei H; Li J; He W; Lu Y; Ma H; Wen X; Huang M; Liu J; Wright DJ; Shan H;
Transfusion; 2012 Mar; 52(3):560-6. PubMed ID: 21895674
[TBL] [Abstract][Full Text] [Related]
75. Prevalence and predictors of adverse reactions in plateletpheresis donors with the perspective of donor safety in a tertiary care hospital of Northern India.
Solanki A; Katharia R; Singh A; Chauhan A; Chandra T; Sonker A; Agarwal P
Asian J Transfus Sci; 2020; 14(1):44-48. PubMed ID: 33162705
[TBL] [Abstract][Full Text] [Related]
76. Periodic acid-Schiff (PAS) staining of immature platelets in donors.
Pogorelov VM; Beskorovainova VJ; Chanieva MI; Dyagileva OA; Naumova IN; Skedina MA
Platelets; 2012; 23(1):51-9. PubMed ID: 21736421
[TBL] [Abstract][Full Text] [Related]
77. [Effect of plateletpheresis on the white blood cell count: meta-analysis 1980-2018].
Gil-Betacur A; Mantilla-Gutierrez CY; Cardona-Arias JA
Rev Esp Salud Publica; 2019 Sep; 93():. PubMed ID: 31537778
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany.
Daskalakis M; Schulz-Huotari C; Burger M; Klink I; Umhau M
J Clin Apher; 2012; 27(2):75-80. PubMed ID: 22362609
[TBL] [Abstract][Full Text] [Related]
79. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
[TBL] [Abstract][Full Text] [Related]
80. Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial.
Heuft HG; Moog R; Fischer EG; Zingsem J;
Transfusion; 2013 Jan; 53(1):211-20. PubMed ID: 22612302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
